From post

Designing and analyzing clinical trials with composite outcomes: consideration of possible treatment differences between the individual outcomes.

, , , и . PloS one, 7 (4): e34785 (января 2012)6637<m:linebreak></m:linebreak>JID: 101285081; OID: NLM: PMC3328496; 2011/11/08 received; 2012/03/09 accepted; 2012/04/17 epublish; ppublish;<m:linebreak></m:linebreak>Comparacions múltiples; Composite endpoints; RCT; Heterogeneïtat.
DOI: 10.1371/journal.pone.0034785

Please choose a person to relate this publication to

To differ between persons with the same name, the academic degree and the title of an important publication will be displayed.

 

Другие публикации лиц с тем же именем

Need for expertise based randomised controlled trials., , , , , , , , , и 3 other автор(ы). BMJ (Clinical research ed.), 330 (7482): 88 (января 2005)Disseny; Aleatorització; RCT; Cirurgia.Secretory phospholipase A(2)-IIA and cardiovascular disease: a mendelian randomization study, , , , , , , , , и 103 other автор(ы). Journal of the American College of Cardiology, 62 (21): 1966–1976 (2013)Associations of fats and carbohydrate intake with cardiovascular disease and mortality in 18 countries from five continents (PURE): a prospective cohort study, , , , , , , , , и 353 other автор(ы). The Lancet, 390 (10107): 2050--2062 (ноября 2017)Designing and analyzing clinical trials with composite outcomes: consideration of possible treatment differences between the individual outcomes., , , и . PloS one, 7 (4): e34785 (января 2012)6637<m:linebreak></m:linebreak>JID: 101285081; OID: NLM: PMC3328496; 2011/11/08 received; 2012/03/09 accepted; 2012/04/17 epublish; ppublish;<m:linebreak></m:linebreak>Comparacions múltiples; Composite endpoints; RCT; Heterogeneïtat.Canadian-led capacity-building in biostatistics and methodology in cardiovascular and diabetes trials: the CANNeCTIN Biostatistics and Methodological Innovation Working Group., , , , , , , , , и 1 other автор(ы). Trials, (января 2011)6243<m:linebreak></m:linebreak>GR: Canadian Institutes of Health Research/Canada; JID: 101263253; OID: NLM: PMC3049182; 2010/11/14 received; 2011/02/18 accepted; 2011/02/18 aheadofprint; epublish;<m:linebreak></m:linebreak>Recursos/Organització; Consulting.Damage to important clinical trials by over-regulation.. Clinical trials (London, England), 7 (6): 622-5 (декабря 2010)5826<m:linebreak></m:linebreak>JID: 101197451; ppublish;<m:linebreak></m:linebreak> <m:linebreak></m:linebreak>Polítiques de recerca.Risks of Overinterpreting Interim Data: Lessons From the TOTAL Trial (Thrombectomy With PCI Versus PCI Alone in Patients With STEMI)., , , , , , , и . Circulation, 137 (2): 206-209 (января 2018)Comparacions múltiples; Early stopping; Exemples.Association of dietary nutrients with blood lipids and blood pressure in 18 countries: a cross-sectional analysis from the PURE study, , , , , , , , , и 434 other автор(ы). The Lancet Diabetes & Endocrinology, 5 (10): 774--787 (октября 2017)